Suppr超能文献

单孔胸腔镜交感神经切断术治疗难治性雷诺现象:一年随访。

Treatment of resistant Raynaud's phenomenon with single-port thoracoscopic sympathicotomy: One-year follow-up.

机构信息

Department of Cardiothoracic Surgery, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

Department of Internal Medicine, division Vascular Medicine, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

出版信息

Semin Arthritis Rheum. 2022 Oct;56:152065. doi: 10.1016/j.semarthrit.2022.152065. Epub 2022 Jul 9.

Abstract

OBJECTIVE

Follow-up of patients with treatment-resistant Raynaud's phenomenon (RP) one-year after single-port thoracoscopic sympathicotomy (SPTS).

METHODS

Eight patients (six males, two females, median age of 45 years) with treatment-resistant RP underwent left-sided SPTS at the third rib (R3), unilaterally. Questionnaires were taken, and number and duration of RP attacks were reported over a 2-week period. Perfusion was assessed with a cooling and recovery procedure at baseline and one year after SPTS. Furthermore, laser speckle contrast analysis, pulse wave velocity, heart rate variability and nailfold capillary microscopy were performed.

RESULTS

One year after SPTS the duration of the attacks of was reduced with 1.9 h in the left hand versus 0.3 h in the right hand. Furthermore, three aspects of the questionnaire showed a significant improvement (role limitations due to physical health (p = 0.017), pain (p = 0.027) and physical functioning (p = 0.025)). The total area under the curve of the total cooling and recovery procedure of the left hand was larger one year after surgery (101 (75-140) at baseline versus 118 (95-190) one year post-operatively, p = 0.012), implying a better perfusion in the fingers. This was mainly due to the improvement during the recovery phase (21 (1-41) at baseline versus 38 (24-43) one year post-operatively, p = 0.028).

CONCLUSION

One year after unilateral R3 SPTS the benefit with regard to the majority of outcome variables persisted, though some effects seem to attenuate. Long-term effects and long-term follow-up results will be investigated in an on-going study.

CLINICAL TRIAL REGISTRATION NUMBER

NCT02680509.

摘要

目的

对难治性雷诺现象(RP)患者进行单端口胸腔镜交感神经切断术(SPTS)治疗 1 年后进行随访。

方法

8 名(6 名男性,2 名女性,中位年龄 45 岁)难治性 RP 患者在第 3 肋(R3)行左侧 SPTS。在 2 周内通过问卷调查报告 RP 发作的次数和持续时间。在基线和 SPTS 治疗 1 年后,通过冷却和恢复过程评估灌注情况。此外,还进行了激光散斑对比分析、脉搏波速度、心率变异性和甲襞毛细血管显微镜检查。

结果

SPTS 治疗 1 年后,左手发作持续时间减少 1.9 小时,右手减少 0.3 小时。此外,问卷的三个方面有显著改善(身体状况所致角色受限(p=0.017)、疼痛(p=0.027)和身体机能(p=0.025))。左手总冷却和恢复过程的总曲线下面积在手术后 1 年更大(基线时为 101(75-140),术后 1 年时为 118(95-190),p=0.012),这意味着手指灌注更好。这主要是由于恢复期的改善(基线时为 21(1-41),术后 1 年时为 38(24-43),p=0.028)。

结论

左侧 R3 SPTS 治疗 1 年后,大多数结局变量的益处仍然存在,尽管有些效果似乎减弱。一项正在进行的研究将调查长期效果和长期随访结果。

临床试验注册号

NCT02680509。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验